CN107997188A - 用于满足机体组织生长和修复需求的组合物及其制备方法 - Google Patents
用于满足机体组织生长和修复需求的组合物及其制备方法 Download PDFInfo
- Publication number
- CN107997188A CN107997188A CN201711414373.3A CN201711414373A CN107997188A CN 107997188 A CN107997188 A CN 107997188A CN 201711414373 A CN201711414373 A CN 201711414373A CN 107997188 A CN107997188 A CN 107997188A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- powder
- composition
- mineral matter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 40
- 230000008467 tissue growth Effects 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 62
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 33
- 239000011707 mineral Substances 0.000 claims abstract description 33
- 235000019742 Vitamins premix Nutrition 0.000 claims abstract description 26
- 239000000463 material Substances 0.000 claims abstract description 25
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims abstract description 22
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 21
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 21
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 21
- 235000013373 food additive Nutrition 0.000 claims abstract description 21
- 239000002778 food additive Substances 0.000 claims abstract description 21
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 21
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 21
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 21
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 21
- 241000276489 Merlangius merlangus Species 0.000 claims abstract description 20
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 19
- 235000009470 Theobroma cacao Nutrition 0.000 claims abstract description 19
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 19
- 230000017423 tissue regeneration Effects 0.000 claims abstract description 19
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 6
- 239000013589 supplement Substances 0.000 claims abstract description 5
- 150000001413 amino acids Chemical class 0.000 claims abstract description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- 229940088594 vitamin Drugs 0.000 claims description 17
- 229930003231 vitamin Natural products 0.000 claims description 17
- 235000013343 vitamin Nutrition 0.000 claims description 17
- 239000011782 vitamin Substances 0.000 claims description 17
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 16
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 16
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 16
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 16
- 235000016709 nutrition Nutrition 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 14
- 230000035764 nutrition Effects 0.000 claims description 14
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 8
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- 229930003316 Vitamin D Natural products 0.000 claims description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- 102000007544 Whey Proteins Human genes 0.000 claims description 8
- 108010046377 Whey Proteins Proteins 0.000 claims description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 235000020958 biotin Nutrition 0.000 claims description 8
- 239000011616 biotin Substances 0.000 claims description 8
- 229960002685 biotin Drugs 0.000 claims description 8
- 229910052802 copper Inorganic materials 0.000 claims description 8
- 239000010949 copper Substances 0.000 claims description 8
- 229960000304 folic acid Drugs 0.000 claims description 8
- 235000019152 folic acid Nutrition 0.000 claims description 8
- 239000011724 folic acid Substances 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 239000011777 magnesium Substances 0.000 claims description 8
- 229910052749 magnesium Inorganic materials 0.000 claims description 8
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 8
- 235000001968 nicotinic acid Nutrition 0.000 claims description 8
- 229960003512 nicotinic acid Drugs 0.000 claims description 8
- 239000011664 nicotinic acid Substances 0.000 claims description 8
- 229940055726 pantothenic acid Drugs 0.000 claims description 8
- 235000019161 pantothenic acid Nutrition 0.000 claims description 8
- 239000011713 pantothenic acid Substances 0.000 claims description 8
- 239000011574 phosphorus Substances 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 239000011591 potassium Substances 0.000 claims description 8
- 229910052700 potassium Inorganic materials 0.000 claims description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 8
- 239000011669 selenium Substances 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- 235000019155 vitamin A Nutrition 0.000 claims description 8
- 239000011719 vitamin A Substances 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 235000019166 vitamin D Nutrition 0.000 claims description 8
- 239000011710 vitamin D Substances 0.000 claims description 8
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 229940045997 vitamin a Drugs 0.000 claims description 8
- 229940046008 vitamin d Drugs 0.000 claims description 8
- 239000011716 vitamin B2 Substances 0.000 claims description 7
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 229930003451 Vitamin B1 Natural products 0.000 claims description 6
- 229930003471 Vitamin B2 Natural products 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 6
- 229960002477 riboflavin Drugs 0.000 claims description 6
- 229960003495 thiamine Drugs 0.000 claims description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 6
- 235000010374 vitamin B1 Nutrition 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 235000019164 vitamin B2 Nutrition 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- 230000037213 diet Effects 0.000 claims description 5
- 235000005911 diet Nutrition 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 235000021119 whey protein Nutrition 0.000 claims description 5
- 238000011049 filling Methods 0.000 claims description 4
- 235000018102 proteins Nutrition 0.000 claims description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims description 4
- 239000011726 vitamin B6 Substances 0.000 claims description 4
- 229940011671 vitamin b6 Drugs 0.000 claims description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- 239000005862 Whey Substances 0.000 claims description 3
- 150000005693 branched-chain amino acids Chemical class 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- 235000020776 essential amino acid Nutrition 0.000 claims description 2
- 239000003797 essential amino acid Substances 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- -1 dimension Plain B12 Chemical compound 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 abstract description 10
- 102000008934 Muscle Proteins Human genes 0.000 abstract description 5
- 108010074084 Muscle Proteins Proteins 0.000 abstract description 5
- 238000001243 protein synthesis Methods 0.000 abstract description 3
- 230000014616 translation Effects 0.000 abstract description 3
- 235000019621 digestibility Nutrition 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 235000010755 mineral Nutrition 0.000 description 24
- 239000011573 trace mineral Substances 0.000 description 8
- 235000013619 trace mineral Nutrition 0.000 description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 102000004407 Lactalbumin Human genes 0.000 description 4
- 108090000942 Lactalbumin Proteins 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 235000001465 calcium Nutrition 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000012549 training Methods 0.000 description 3
- 206010001497 Agitation Diseases 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 150000003254 radicals Chemical group 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 208000015001 muscle soreness Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003617 peroxidasic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供了一种用于满足机体组织生长和修复需求的组合物及其制备方法，所述组合物由蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂组成，按其重量份数计蛋白粉50‑90份、可可粉5‑13份、粉末磷脂粉0.1‑0.5份、微晶纤维素0.5‑1.2份、麦芽糊精2‑6.8份、重质碳酸钙0.2‑0.73份、维生素预混料0.2‑0.7份、矿物质及微量元素预混料0.1‑0.48份、食品添加剂0.25‑3.2份，通过混合方式获得；含有丰富的高消化率、氨基酸组成合理的优质蛋白，所述组合物各组分协同作用，补充运动时蛋白质的消耗，增加肌肉的力量，促进肌肉蛋白质合成，更加适合运动人群的需求。
Description
技术领域
本发明涉及功能性食品领域，尤其是一种用于满足机体组织生长和修复需求的组合物及其制备方法
背景技术
运动营养食品是在食品门类中较新的概念，在不同的国家定义有相似之处，但也不完全相同，运动营养食品均归类于“特殊膳食”。运动营养食品是为满足运动人群的生理代谢状态、运动能力及对某些营养成分的特殊需求专门加工的食品。
近几年来，国内外的运动营养品市场规模发展迅速，使用方便，具有一定功能的运动营养食品占得市场份额越来越大。2010年美国运动营养市场总销售额达到100亿元，每年约有10亿美元新产品进入市场。我国运动营养食品市场，2004年已形成10亿-15亿元的规模，2008年达50亿元的规模，运动营养食品还存在着相当大的市场增长空间。
我国运动营养食品是按照特征营养素的添加和产品消费者所从事的运动类型进行分类。特征营养素包括能量补充、能量控制和蛋白质补充；消费者所从事的运动类型包括速度、力量、耐力运动或运动后帮助恢复的产品。
发明内容
本发明所要解决的技术问题在于提供一种用于满足机体组织生长和修复需求的组合物，所述组合物为运动营养特殊膳食食品，具有促进机体组织肌肉蛋白的生长及修复的功效。
本发明所要解决的另一技术问题在于提供上述用于机体组织生长和修复需求的组合物的制备方法。
为解决上述技术问题，本发明的技术方案是：
一种用于满足机体组织生长和修复需求的组合物，由蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂组成，按其重量份数计蛋白粉50-90份、可可粉5-13份、粉末磷脂粉0.1-0.5份、微晶纤维素0.5-1.2份、麦芽糊精2-6.8份、重质碳酸钙0.2-0.73份、维生素预混料0.2-0.7份、矿物质及微量元素预混料0.1-0.48份、食品添加剂0.25-3.2份，其中，
所述维生素预混料由维生素A、维生素D、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、生物素、泛酸组成，各组分按重量份数计为：维生素A0.15-0.45份，维生素D 0.001-0.01份，维生素E 1-15份，维生素B1 0.5-4.8份，维生素B20.3-0.72份，维生素B6 0.4-0.96份，维生素B12 0.001-0.005份，维生素C 62-85份，烟酸4-10份，叶酸0.01-0.25份，生物素0.01-0.05份，泛酸1-4.5份(各维生素所占重量份数仅为维生素之间的重量份数关系，并非与组合物整体组方中其他组分的份数关系)；
所述矿物质及微量元素预混料由磷、钾、镁、铁、锌、碘、硒、铜、锰、牛磺酸组成，各组分按重量份数计为：磷20-32份，钾30-65份，镁4-12份，铁0.2-0.8份，锌0.39-1份，碘0.001-0.008份，硒0.0005-0.007份，铜0.03-0.1份，锰0.08-0.4份，牛磺酸12-22份(各矿物质及微量元素所占重量份数仅为矿物质及微量元素之间的重量份数关系，并非与组合物整体组方中其他组分的份数关系)。
优选的，上述用于满足机体组织生长和修复需求的组合物，食品添加剂为香精、黄原胶、羧甲基纤维素钠中的一种或任意组合。
优选的，上述用于满足机体组织生长和修复需求的组合物，所述维生素预混料各组分按重量份数计为：维生素A 0.29份、维生素D 0.004份、维生素E 7.075份、维生素B11.83份、维生素B2 0.51份、维生素B6 0.71份、维生素B12 0.002份、维生素C 80.45份、烟酸6.75份、叶酸0.13份、生物素0.02份、泛酸2.24份。
优选的，上述用于满足机体组织生长和修复需求的组合物，所述矿物质及微量元素预混料各组分按重量份数计为：磷23.49份，钾51.51份，镁8.785份，铁0.59份，锌0.42份，碘0.004份，硒0.001份，铜0.08份，锰0.12份，牛磺酸15份。
优选的，上述用于满足机体组织生长和修复需求的组合物，按其重量份数计蛋白粉83份、可可粉8份、粉末磷脂粉0.3份、微晶纤维素0.8份、麦芽糊精4.2份、重质碳酸钙0.45份、维生素预混料0.65份、矿物质及微量元素预混料0.25份、食品添加剂2.35份。
优选的，上述用于满足机体组织生长和修复需求的组合物，所述蛋白粉由分离乳清蛋白和浓缩乳清蛋白组成，其中，各组分按其重量百分比计分离乳清蛋白88.5％、浓缩乳清蛋白11.5％。
上述用于满足机体组织生长和修复需求的组合物的制备方法，具体步骤如下：
(1)按组方量称取蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂，备用；
(2)混料：先将微晶纤维素、重质碳酸钙、维生素预混料、矿物质及微量元素预混料、食品添加剂进行混合5-20mi n；再将余下的原料加入混料罐，总混30-60mi n；
(3)杀菌清洁、灌装，即得。
本发明的有益效果是：
所述用于满足机体组织生长和修复需求的组合物，根据需求可制作成运动营养特殊膳食、固体饮料等等其他的形式。含有丰富的高消化率、氨基酸组成合理的优质蛋白，补充运动时蛋白质的消耗，增加肌肉的力量，促进肌肉蛋白质合成，各组分协同作用，能够有助于改善恢复运动后肌肉蛋白质的合成、提供大量必需的氨基酸以及支链氨基酸，同时氨基酸的特定配比更为接近特定时期人体需要，且有利于肌肉的增长和力量的增加；在运动中可以帮助抗体疲劳，延缓中枢神经系统的疲劳，抗肌肉分解，更好的提高运动耐力，其制备方法简单，适合规模化工业生产的需要。
具体实施方式
实施例1
一种用于满足机体组织生长和修复需求的组合物，由蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂(羧甲基纤维素钠)组成，按其重量份数计蛋白粉83份、可可粉8份、粉末磷脂粉0.3份、微晶纤维素0.8份、麦芽糊精4.2份、重质碳酸钙0.45份、维生素预混料0.65份、矿物质及微量元素预混料0.25份、食品添加剂2.35份，所述蛋白粉由分离乳清蛋白和浓缩乳清蛋白组成，该蛋白粉组分中按其重量百分比计分离乳清蛋白88.5％、浓缩乳清蛋白11.5％，其中，
所述维生素预混料由维生素A、维生素D、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、生物素、泛酸组成，各组分按重量份数计为：维生素A 0.29份、维生素D 0.004份、维生素E 7.075份、维生素B1 1.83份、维生素B2 0.51份、维生素B60.71份、维生素B12 0.002份、维生素C 80.45份、烟酸6.75份、叶酸0.13份、生物素0.02份、泛酸2.24份(各维生素所占重量份数仅为维生素之间的重量份数关系，并非与组合物整体组方中其他组分的份数关系)；
所述矿物质及微量元素预混料由磷、钾、镁、铁、锌、碘、硒、铜、锰、牛磺酸组成，各组分按重量份数计为：磷23.49份，钾51.51份，镁8.785份，铁0.59份，锌0.42份，碘0.004份，硒0.001份，铜0.08份，锰0.12份，牛磺酸15份(各矿物质及微量元素所占重量份数仅为矿物质及微量元素之间的重量份数关系，并非与组合物整体组方中其他组分的份数关系)。
上述用于满足机体组织生长和修复需求的组合物的制备方法，具体步骤如下：
(1)按组方量称取蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂，备用；
(2)混料：先将微晶纤维素、重质碳酸钙、维生素预混料、矿物质及微量元素预混料、食品添加剂进行混合10mi n；再将余下的原料加入混料罐，总混50mi n；
(3)杀菌清洁、灌装，即得。
实施例2
一种用于满足机体组织生长和修复需求的组合物，由蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂(黄原胶)组成，按其重量份数计蛋白粉90份、可可粉5份、粉末磷脂粉0.5份、微晶纤维素1.2份、麦芽糊精2份、重质碳酸钙0.73份、维生素预混料0.2份、矿物质及微量元素预混料0.48份、食品添加剂3.2份。
其他同实施例1。
实施例3
一种用于满足机体组织生长和修复需求的组合物，由蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂(香精)组成，按其重量份数计蛋白粉50份、可可粉13份、粉末磷脂粉0.1份、微晶纤维素0.5份、麦芽糊精6.8份、重质碳酸钙0.2份、维生素预混料0.7份、矿物质及微量元素预混料0.1份、食品添加剂0.25份。
其他同实施例1。
实施例4
一种用于满足机体组织生长和修复需求的组合物，由蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂(羧甲基纤维素钠)组成，按其重量份数计蛋白粉77份、可可粉12份、粉末磷脂粉0.3份、微晶纤维素0.8份、麦芽糊精6.2份、重质碳酸钙0.45份、维生素预混料0.65份、矿物质及微量元素预混料0.25份、食品添加剂2.35份。
其他同实施例1。
上述用于满足机体组织生长和修复需求的组合物中各组分均为市售产品，其中，
乳清蛋白是利用现代生产工艺从牛奶中提取出来的一种具有高生物利用效价的蛋白质；具有抗氧化、增加免疫功能、提高骨质、控制体重等功能。乳清蛋白含有丰富的天然之链氨基酸的来源。支链氨基酸中的亮氨酸在启动肌肉蛋白合成中起着重要的作用，亮氨酸及其氧化产物能抑制蛋白水解酶的活性，有助于肌肉蛋白质合成，增加瘦体重。研究表明，在负重运动或抗组运动以后，可以很大程度地促进肌肉合成，邦之保持肌肉质量的良好状态，增加肌肉力量和做功能力，促进人体脂肪的燃烧，有助于减肥。还可以很大程度上促进肌肉组织的恢复，缩短免疫抑制时间、有效缓解运动后肌肉酸痛感。
牛磺酸存在于身体的大部分器官和组织中，维持身体功能的正常运作与平衡。牛磺酸能调节各种原因(包括运动)所指的钙离子稳态失调，能双向调节纤维。运动是自由基的生成增加，造成细胞膜的损伤，补充牛磺酸能够减少运动后脂质过氧化反应，保护细胞免受氧化剂和自由基的攻击。
维生素是人和动物营养及生长所必需的某些少量有机化合物，对机体的新陈代谢、生长、发育、健康有极重要作用。研究表明，维生素的缺乏在运动员群体中缺乏已经很普遍。维生素A缺乏可导致暗视力下降，不仅可引起呼吸道、肠道风上皮细胞变性，还可能使细胞免疫、体液免疫功能下降，维生素C是维护免疫系统的生力军，是所有细胞的重要成分。维生素B1缺乏可导致肌力下降、肌肉酸痛等症状。维生素B2是体内辅酶的构成成分，参与物质代谢，对三大能源物质的彻底氧化功能起着重要作用。
对运动员来说。矿物质的含量甚微，但作用非常大。矿物质可以调节运动员神经系统的兴奋性、参与免疫应答反应、防止生物氧化、运动训练中运动员出汗较多，几个月的连续大量出汗会带来铁的流失，缺铁，体内就不能生成足量的血红素，运送到肌肉的氧气量也会减少，从而影响运动员的发挥。钙和锌的缺乏，会对运动员的神经兴奋性和机体水平造成不良影响。钙与肌肉收缩、神经信号传导以及体液环境的稳定有着密切的关系。
综上，本发明所述组方将各组分协同作用，从多方面对食用者进行调节，提供了运动者的每日营养需求以及能量需求，促进机体组织生长和修复。
实验例
96名健康志愿者(年龄介于20到67岁)，平均分成两组，进行为期8周的举重训练计划，一组48人为试验组给予实施例1所述组合物，另一组48人为对照组给予相同量的安慰剂(麦芽糊精)。
参与者每周训练三次，训练12周(包括二头肌卷曲、三头肌卷曲、腿卷曲、腿压、腿部扩展等)，每次训练后根据分组分别给予70克的实施例1所述组合物或70克的麦芽糊精(调成相同体积的液体)。
结果：对照组无显著性变化。试验组平均肌肉力量增加35％，大腿肌肉厚度增加5％(p＜0.05)。
上述参照实施例对该种满足机体组织生长和修复需求的组合物及其制备方法进行的详细描述，是说明性的而不是限定性的，可按照所限定范围列举出若干个实施例，因此在不脱离本发明总体构思下的变化和修改，应属本发明的保护范围之内。
Claims (9)
1.一种用于满足机体组织生长和修复需求的组合物，其特征在于：由蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂组成，按其重量份数计蛋白粉50-90份、可可粉5-13份、粉末磷脂粉0.1-0.5份、微晶纤维素0.5-1.2份、麦芽糊精2-6.8份、重质碳酸钙0.2-0.73份、维生素预混料0.2-0.7份、矿物质及微量元素预混料0.1-0.48份、食品添加剂0.25-3.2份，其中，
所述维生素预混料由维生素A、维生素D、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、生物素、泛酸组成，各组分按重量份数计为：维生素A 0.15-0.45份，维生素D 0.001-0.01份，维生素E 1-15份，维生素B1 0.5-4.8份，维生素B2 0.3-0.72份，维生素B6 0.4-0.96份，维生素B12 0.001-0.005份，维生素C 62-85份，烟酸4-10份，叶酸0.01-0.25份，生物素0.01-0.05份，泛酸1-4.5份；
所述矿物质及微量元素预混料由磷、钾、镁、铁、锌、碘、硒、铜、锰、牛磺酸组成，各组分按重量份数计为：磷20-32份，钾30-65份，镁4-12份，铁0.2-0.8份，锌0.39-1份，碘0.001-0.008份，硒0.0005-0.007份，铜0.03-0.1份，锰0.08-0.4份，牛磺酸12-22份。
2.根据权利要求1所述的用于满足机体组织生长和修复需求的组合物，其特征在于：所述维生素预混料各组分按重量份数计为：维生素A 0.29份、维生素D 0.004份、维生素E7.075份、维生素B1 1.83份、维生素B20.51份、维生素B6 0.71份、维生素B12 0.002份、维生素C 80.45份、烟酸6.75份、叶酸0.13份、生物素0.02份、泛酸2.24份。
3.根据权利要求1所述的用于满足机体组织生长和修复需求的组合物，其特征在于：所述矿物质及微量元素预混料各组分按重量份数计为：磷23.49份，钾51.51份，镁8.785份，铁0.59份，锌0.42份，碘0.004份，硒0.001份，铜0.08份，锰0.12份，牛磺酸15份。
4.根据权利要求1所述的用于满足机体组织生长和修复需求的组合物，其特征在于：按其重量份数计蛋白粉83份、可可粉8份、粉末磷脂粉0.3份、微晶纤维素0.8份、麦芽糊精4.2份、重质碳酸钙0.45份、维生素预混料0.65份、矿物质及微量元素预混料0.25份、食品添加剂2.35份。
5.根据权利要求1所述的用于满足机体组织生长和修复需求的组合物，其特征在于：所述蛋白粉由分离乳清蛋白和浓缩乳清蛋白组成，其中，各组分按其重量百分比计分离乳清蛋白88.5％、浓缩乳清蛋白11.5％。
6.根据权利要求1所述的补充蛋白类运动营养特殊膳食食品，其特征在于：优质蛋白所占比例不低于50％。
7.根据权利要求1所述的补充蛋白类运动营养特殊膳食食品，其特征在于：粉状产品蛋白质含量≥50g/100g，脂肪含量≤6g/100g。
8.根据权利要求1所述的补充蛋白类运动营养特殊膳食食品，其特征在于：含有丰富的氨基酸以及必需氨基酸，其中支链氨基酸的含量可高达10～20％。
9.权利要求1所述用于满足机体组织生长和修复需求的组合物的制备方法，其特征在于：具体步骤如下：
(1)按组方量称取蛋白粉、可可粉、粉末磷脂粉、微晶纤维素、麦芽糊精、重质碳酸钙、维生素预混料、矿物质及微量元素预混料和食品添加剂，备用；
(2)混料：先将微晶纤维素、重质碳酸钙、维生素预混料、矿物质及微量元素预混料、食品添加剂进行混合5-20min；再将余下的原料加入混料罐，总混30-60min；
(3)杀菌清洁、灌装，即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711414373.3A CN107997188A (zh) | 2017-12-25 | 2017-12-25 | 用于满足机体组织生长和修复需求的组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201711414373.3A CN107997188A (zh) | 2017-12-25 | 2017-12-25 | 用于满足机体组织生长和修复需求的组合物及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107997188A true CN107997188A (zh) | 2018-05-08 |
Family
ID=62060831
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201711414373.3A Pending CN107997188A (zh) | 2017-12-25 | 2017-12-25 | 用于满足机体组织生长和修复需求的组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107997188A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103070239A (zh) * | 2011-10-25 | 2013-05-01 | 北京康比特体育科技股份有限公司 | 一种缓解运动疲劳的乳制品及其制备方法 |
| CN106942394A (zh) * | 2017-03-31 | 2017-07-14 | 兰州乾辰运动科技有限公司 | 一种浓缩型乳清蛋白饮料配方及其生产流程 |
-
2017
- 2017-12-25 CN CN201711414373.3A patent/CN107997188A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103070239A (zh) * | 2011-10-25 | 2013-05-01 | 北京康比特体育科技股份有限公司 | 一种缓解运动疲劳的乳制品及其制备方法 |
| CN106942394A (zh) * | 2017-03-31 | 2017-07-14 | 兰州乾辰运动科技有限公司 | 一种浓缩型乳清蛋白饮料配方及其生产流程 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101181018B (zh) | 生产保健鸡蛋的蛋鸡饲料 | |
| CN106819385B (zh) | 一种哺乳母猪浓缩饲料 | |
| CN102172265A (zh) | 一种提高生长育肥猪抗应激能力和肉色肉质的饲料添加剂及应用 | |
| CN104544432B (zh) | 一种翅果油复合蛋白固体饮料及其制备方法 | |
| CN108244252A (zh) | 益生菌多元蛋白粉及其制备方法 | |
| CN106578518A (zh) | 一种抗热应激型种公猪专用浓缩饲料 | |
| CN101011088A (zh) | 一种犊牛代乳粉 | |
| CN108142927A (zh) | 一种用于满足运动控制体重需求的组合物及其制备方法 | |
| CN103070241A (zh) | 一种纯羊乳蛋白婴幼儿配方羊奶粉及其制备方法 | |
| CN108477622A (zh) | 一种婴幼儿全功能营养组合物 | |
| CN103564262B (zh) | 一种大猪饲料 | |
| CN107183372B (zh) | 一种用于肉用犊牛断奶的代乳料 | |
| CN105432792A (zh) | 一种学龄前儿童基础营养奶粉、营养粉套装及制备方法 | |
| CN101715892B (zh) | 一种改良肉质的猪用复合预混料 | |
| CN111134244A (zh) | 一种动物高蛋白营养膏及其制备方法 | |
| CN105613972A (zh) | 一种富维生素b2鸡蛋的生产方法 | |
| Howe et al. | An approach toward the solution of the world food problem with special emphasis on protein supply | |
| CN107927198A (zh) | 一种用于早产儿饮用奶粉及其制备方法 | |
| CN114190441A (zh) | 一种促进儿童身高发育的配方奶粉及其制备方法 | |
| CN110973645A (zh) | 一种具有脑神经营养作用的蛋白粉 | |
| CN103583847A (zh) | 一种生产高维生素e鸡蛋的蛋鸡饲料 | |
| CN109892495A (zh) | 一种富硒、锌和铁鸡饲料及富硒、锌和铁鸡蛋的生产方法 | |
| CN107997188A (zh) | 用于满足机体组织生长和修复需求的组合物及其制备方法 | |
| CN101120793A (zh) | 一种功能性学生营养食品配料的添加应用方法 | |
| CN103690564A (zh) | 林蛙高蛋白钙粉在制备抗疲劳保健品或药物中的应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180508 |
|
| RJ01 | Rejection of invention patent application after publication |